ALHC

Alignment Healthcare, Inc.

Fundamental data last updated:June 6, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Healthcare

industry

Medical - Healthcare Plans

Exchange

NASDAQ

County of HQ

US

Next Earnings Date

07/30/2026

Business Summary

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.

 


Analyze ALHC on TradingView

VALUATION

P/E

164.49

Market Cap ($M USD)

$3.28B

Forward P/E

9.44

PEG

0.01

PRICE TO SALES

0.77

PRICE TO BOOK

15.75

EV / EBITDA

33.10

5-Year Average P/E

Free Cash Flow Yield

7.21%

DCF Value

$-80.49

Graham Number

$1.48

Price to FCF

13.86

EV to FCF

9.29

Earnings Yield

0.61%

FCF Yield

7.21%

DIVIDEND

Yield

0.00%

Annual Payout

$0.00

Payout Ratio

0.00%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$0.10

Next Year EPS Growth Estimate

$1.68

Next Year Revenue Growth Estimate

$1.37T

Return on Equity (ROE)

11.50%

FREE CASH FLOW

Operating Margin

0.84%

Debt-to-Equity

1.89

Piotroski F-Score

6

Altman Z-Score

4.71

Return on Invested Capital (ROIC)

5.89%

Current Ratio

1.75

Quick Ratio

1.75

Net Debt to EBITDA

-16.28

Interest Coverage

2.24

Gross Profit margin

12.38%

FCF PER SHARE

$1.15

REVENUE PER SHARE

$20.73

Analyze ALHC on TradingView

Gainseekers Quantitative Analysis

Summary

The market seems to be mispricing ALHC significantly. Despite a staggering DCF value that suggests a negative outlook, the stock’s Forward P/E of 10.67 indicates potential undervaluation relative to future earnings. The Altman Z-score of 4.86 suggests financial stability, while the Earnings Yield of 0.54% raises questions about immediate profitability. With a Price/Book ratio of 17.80, the stock appears expensive, yet the high ROE of 11.50% reflects competent management and effective capital use.

AI Exposure / Tech Reliance

Operating in the healthcare plans industry, ALHC is well-positioned to leverage AI for personalized healthcare solutions and data analytics. This sector's inherent need for efficiency and cost management aligns with AI advancements. As technology reshapes healthcare, ALHC's adaptability could enhance its competitive edge.

The Bull Case

For the discerning GARP investor, ALHC offers compelling strengths. The ROIC of 5.89% and a Piotroski F-Score of 6 indicate solid operational efficiency and financial health. Its FCF Yield of 6.38% suggests robust cash generation, while a modest operating margin of 0.84% hints at potential for improvement. These metrics collectively paint a picture of a company with pricing power and capital efficiency, poised for growth.

The Bear Case

Despite its strengths, ALHC faces significant structural risks. The Price/Book ratio of 17.80 and Price/Sales of 0.87 suggest overvaluation, especially when juxtaposed with a modest EPS of $0.10. The stock's proximity to its 52-week high, coupled with an EV to EBITDA of 39.53, indicates technical overextension. Furthermore, the zero dividend yield and payout ratio highlight a lack of immediate income for investors.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$24.33

Institutional Ownership %

1-Year Beta

1.27

Insider Buying % (6 Mo)

Distance to 52-Week High

50.46%

Distance to 52-Week Low

26.73%

EARNINGS SURPRISE %

400.00%

50-DAY SMA

$18.82

200-DAY SMA

$18.54

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.